Dalton Investments’ response to the anti-takeover measures adopted by Aska Pharma and Bunka Shutter—two companies in which it is a major shareholder—was recently featured in Nikkei Asia. Read the article here.
Dalton Investments’ response to the anti-takeover measures adopted by Aska Pharma and Bunka Shutter—two companies in which it is a major shareholder—was recently featured in Nikkei Asia. Read the article here.